15997-62-3

Basic information

• Product Name: ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER
• Synonyms: ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER;2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ACETATE;4-(Acetyloxy)-2H,3H-pyran-2,6-dione;2H-Pyran-2,6(3H)-dione, 4-(acetyloxy)-
• CAS NO: 15997-62-3
• Molecular Formula: C₇H₆O₅
• Molecular Weight: 170.11954
• Mol File: 15997-62-3.mol
• Article Data: 4

Chemical Properties

• Melting Point: 90-92℃
• Boiling Point: 322℃
• Flash Point: 146℃
• Appearance: /
• Density: 1.38
• Vapor Pressure: 0.000294mmHg at 25°C
• Refractive Index: 1.495
• CAS DataBase Reference: ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER(15997-62-3)
• EPA Substance Registry System: ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER(15997-62-3)

Safety Data

• Hazardous Substances Data: 15997-62-3(Hazardous Substances Data)

Usage

General Description

ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER is a chemical compound that belongs to the ester group. It is derived from acetic acid and 2,6-dioxo-3,6-dihydro-2H-pyran-4-yl. ACETIC ACID 2,6-DIOXO-3,6-DIHYDRO-2H-PYRAN-4-YL ESTER is commonly used as a flavor and fragrance ingredient and it often have a sweet, fruity odor. It is also used in the production of perfumes, soaps, and other personal care products. Additionally, it can be used as a solvent in various industrial processes and as a plasticizer in polymer production. However, it is important to handle this chemical with care as it may be hazardous if not properly managed.

InChI:InChI=1/C7H6O5/c1-4(8)11-5-2-6(9)12-7(10)3-5/h2H,3H2,1H3

Upstream product

• 542-05-2 acetonedicarboxylic acid 
• 108-24-7 acetic anhydride 

Downstream Products

• 1155270-66-8 C₁₄H₁₄BrNO₆ 
• 1155419-89-8 2-(tert-butoxy)-2-((R)-4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid 
• 1402714-51-5 methyl 2-(tert-butoxy)-2-((R)-4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetate 
• 1402714-51-5 methyl 2-(tert-butoxy)-2-((S)-4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetate 
• 1155419-89-8 BI-224436 
• 1402714-51-5 C₂₈H₂₈N₂O₄ 
• 1155270-72-6 7-bromo-2,3-dihydropyrano[4,3,2-de]quinoline 
• 1155270-71-5 7-bromo-5-chloro-2,3-dihydropyrano[4,3,2-de]quinoline 
• 1155270-69-1 8-bromo-5-hydroxy-4-(2-hydroxyethyl)quinolin-2(1H)-one 
• 214045-56-4 3-(acetyloxy)-5-[(3-fluorophenyl)amino]-5-oxopent-2-enoic acid 
• 189003-92-7 Trelanserin 
• 21298-80-6 2-(2-oxo-1,2-dihydroquinoline-4-yl)acetic acid 

Relevant articles and documents

PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR

The present invention is directed to an improved process for the preparation of Compounds of Formula (I) or salts thereof which are useful in the treatment of HIV infection. In particular, the present invention is directed to an improved process for the preparation of (2S)-2-tert-butoxy-2-(4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)- 2-methylquinolin-3-yl)acetic acid or salt thereof which is useful in the treatment of HIV infection. R4 is selected from the group consisting of (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n) and (o); and R6 and R7 are each independently selected from H, halo and (C1-6) alkyl.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula (I): wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.